3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
3
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Non Small Cell Lung Carcinoma NSCLC
1
Lung Neoplasms
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Interventions
Paclitaxel
9
Carboplatin
6
liposomal doxorubicin
4
Bevacizumab
4
Topotecan
3
Cyclophosphamide
3
oregovomab
2
olaparib
2
niraparib
2
fludarabine
2
Nivolumab
2
trastuzumab deruxtecan
1
rucaparib
1
ribociclib
1
pembrolizumab
1
palbociclib
1
mirvetuximab soravtansine
1
isoquercitrin
1
irinotecan sucrosofate
1
fludarabine phosphate
1
denileukin diftitox
1
anlotinib
1
Tinzaparin
1
Propranolol
1
Preoperative Exercise
1
Palliative Care
1
Neoadjuvant Therapy
1
Music Therapy
1
Metformin
1
MORAb-202
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
CP protocol
×
90 days
×
Clear all
No trials found.